PSNL Logo

Personalis, Inc. (PSNL) 

NASDAQ$3.63
Market Cap
$320.4M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
33 of 924
Rank in Industry
2 of 49

PSNL Insider Trading Activity

PSNL Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$17,745,00015
Sells
$248,0031895

Related Transactions

Tempus AI, Inc.10 percent owner1$17.75M0$0$17.75M
Moore Stephen MichaelSVP and Chief Legal Officer0$05$22,826$-22,826
Chen RichardCHIEF MEDICAL OFFICER AND EVP0$06$34,336$-34,336
Tachibana AaronCFO AND COO0$06$48,577$-48,577
Hall Christopher MPRESIDENT AND CEO0$01$142,263$-142,263

About Personalis, Inc.

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT â€¦

Insider Activity of Personalis, Inc.

Over the last 12 months, insiders at Personalis, Inc. have bought $17.75M and sold $248,003 worth of Personalis, Inc. stock.

On average, over the past 5 years, insiders at Personalis, Inc. have bought $20.12M and sold $19.46M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Tempus AI, Inc. (10 percent owner) — $17.75M.

The last purchase of 3,500,000 shares for transaction amount of $17.75M was made by Tempus AI, Inc. (10 percent owner) on 2024‑08‑16.

List of Insider Buy and Sell Transactions, Personalis, Inc.

2025-01-28SaleTachibana AaronCFO AND COO
708
0.001%
$5.79$4,099-13.97%
2025-01-28SaleChen RichardCHIEF MEDICAL OFFICER AND EVP
519
0.0008%
$5.79$3,005-13.97%
2024-12-16SaleTachibana AaronCFO AND COO
6,865
0.0098%
$3.82$26,224+39.35%
2024-12-16SaleChen RichardCHIEF MEDICAL OFFICER AND EVP
4,834
0.0069%
$3.82$18,466+39.35%
2024-12-16SaleMoore Stephen MichaelSVP and Chief Legal Officer
1,513
0.0022%
$3.82$5,780+39.35%
2024-11-18SaleTachibana AaronCFO AND COO
1,307
0.002%
$3.79$4,954+34.68%
2024-11-18SaleChen RichardCHIEF MEDICAL OFFICER AND EVP
921
0.0014%
$3.79$3,491+34.68%
2024-11-18SaleMoore Stephen MichaelSVP and Chief Legal Officer
1,693
0.0025%
$3.79$6,416+34.68%
2024-11-01SaleHall Christopher MPRESIDENT AND CEO
26,443
0.0527%
$5.38$142,263-6.09%
2024-08-16PurchaseTempus AI, Inc.10 percent owner
3.5M
7.8698%
$5.07$17.75M-15.69%
2024-07-30SaleTachibana AaronCFO AND COO
742
0.0014%
$2.97$2,204+60.10%
2024-07-30SaleChen RichardCHIEF MEDICAL OFFICER AND EVP
524
0.001%
$2.97$1,556+60.10%
2024-06-17SaleTachibana AaronCFO AND COO
7,176
0.0134%
$1.29$9,257+270.54%
2024-06-17SaleChen RichardCHIEF MEDICAL OFFICER AND EVP
5,055
0.0094%
$1.29$6,521+270.54%
2024-06-17SaleMoore Stephen MichaelSVP and Chief Legal Officer
1,585
0.003%
$1.29$2,045+270.54%
2024-05-17SaleTachibana AaronCFO AND COO
1,333
0.0026%
$1.38$1,840+230.00%
2024-05-17SaleChen RichardCHIEF MEDICAL OFFICER AND EVP
940
0.0018%
$1.38$1,297+230.00%
2024-05-17SaleMoore Stephen MichaelSVP and Chief Legal Officer
1,731
0.0033%
$1.38$2,389+230.00%
2024-04-30SaleMoore Stephen MichaelSVP and Chief Legal Officer
4,523
0.0083%
$1.37$6,197+203.40%
2024-03-01PurchaseMYERS WOODROW A JRdirector
10,000
0.0206%
$1.67$16,700+127.22%
Total: 134
*Gray background shows transactions not older than one year

Insider Historical Profitability

16.18%
Tempus AI, Inc.10 percent owner
12718800
14.4101%
$46.17M10
Lightspeed Venture Partners Select IV, L.P.director
1774240
2.0102%
$6.44M30+58.12%
LUDLUM KENdirector
30000
0.034%
$108,900.0011<0.0001%
MYERS WOODROW A JRdirector
26116
0.0296%
$94,801.0810+127.22%
RICCI PAULdirector
20000
0.0227%
$72,600.0010<0.0001%
*Gray background shows insiders who have made transactions during last year

PSNL Institutional Investors: Active Positions

Increased Positions57+56.44%26M+87.77%
Decreased Positions42-41.58%3M-11.65%
New Positions33New23MNew
Sold Out Positions7Sold Out324,723Sold Out
Total Postitions116+14.85%52M+76.12%

PSNL Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Merck & Co., Inc.$58,146.0019.78%14.04M+14MNew2024-12-31
Lightspeed Management Company, L.L.C.$33,785.0011.49%8.16M+8MNew2024-12-31
Ark Investment Management Llc$28,050.009.54%6.78M-310,088-4.38%2024-12-31
Aigh Capital Management Llc$15,728.005.35%3.8M-200,000-5%2024-12-31
Blackrock, Inc.$12,234.004.16%2.96M+39,487+1.35%2024-12-31
Vanguard Group Inc$7,182.002.44%1.73M-235,711-11.96%2024-12-31
Millennium Management Llc$5,454.001.86%1.32M-1M-45.91%2024-12-31
Blue Water Life Science Advisors, Lp$4,690.001.6%1.13M+132,900+13.29%2024-12-31
Renaissance Technologies Llc$3,812.001.3%920,868-10,243-1.1%2024-12-31
Susquehanna International Group, Llp$3,615.001.23%873,097+718,336+464.16%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
1.83SellsBuysStrong BuyBuyHoldSellStrong SellPSNLHighAverageLowSeries 4